ACE-536-B-THAL-001 - A Phase 3, double-blind, randomized, placebo-controlled, multicenter study to determine the efficacy and safety of luspatercept (ACE-536) versus placebo in adults who require regular red blood cell transfus

Project: Research project

Project Details

StatusActive
Effective start/end date6/1/168/31/50

Funding

  • Celgene Corporation
  • Celgene Corporation